“Cell therapy has the potential to change how we treat heart failure,” one researcher said.

The cardiologist's message has been spread throughout Malaysia and other parts of the world.

The two-part document was published in full in European Heart Journal. 

The company reported that its deep neural network led to improved sensitivity and fewer unclassified findings. 

The analysis, presented at AHA Scientific Sessions 2021, included approximately 2,000 symptomatic COVID-19 patients who were not necessarily sick enough to be hospitalized. 

The AHA believes the next FDA commissioner should play a key role in influencing public health post-COVID-19.

The solution provides users with an interactive 3D map of the patient's heart.

Even though automated external defibrillators are available in public places, most out-of-hospital cardiac arrests happen in the home.

Doctors armed with these new tools can spot early signs of chronic liver diseases, which is crucial to possibly reversing progression.